Table 2.
Demographics.
| Lorcaserin group (n = 9) | Placebo group (n = 4) | p | |
|---|---|---|---|
| Gender (males/females) | 8/1 | 3/1 | 0.522 |
| Age, mean ± SD | 47.8 ± 5.29 | 56.3 ± 2.06 | 0.011* |
| Race (African American/Caucasian) | 7/2 | 4/0 | 0.285 |
| Weight (lbs.) mean ± SD | 62 ± 6.8 | 171 ± 34.1 | 0.639 |
| Number of regular cocaine users | 9 | 4 | |
| Years of cocaine use, mean ± SD | 15.7 ± 10.2 | 20.75 ± 10.2 | 0.429 |
| Number of regular alcohol users | 4 | 1 | |
| Years of alcohol use, mean ± SD | 15.8 ± 14.7 | 9.50 ± 17.1 | 0.512 |
| Number of regular cigarette smokers | 4 | 2 | |
| Years of smoking use, mean ± SD | 20.4 ± 15.0 | 32.0 ± 11.8 | 0.203 |
| Number of regular marijuana smokers | 6 | 2 | |
| Years of marijuana use, mean ± SD | 17.6 ± 14.4 | 18.0 ± 9.17 | 0.962 |
SD, standard deviation;
*
p ≤ 0.05.